PROTHENA CORP PUBLIC LTD CO (PRTA)

↓ Download CSV

CIK 0001559053 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated L2
  • Fiscal year ends Dec 31

In fiscal 2025, PROTHENA CORP PUBLIC LTD CO reported revenue of $9.68M, down 92.8% from the prior year. The company ran a net loss, with a net margin of -2520.6%. It held $326.80M in total assets against $46.33M in total liabilities.

Key ratios (FY2025)

-2216.4%
Operating margin
-2520.6%
Net margin
-87.0%
Return on equity
-92.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$9.68M$135.16M$91.37M$53.91M$200.58M$853.0K$814.0K$955.0K
Operating Income-$214.64M-$154.56M-$191.04M-$131.56M$71.97M-$112.73M-$85.70M-$158.85M-$155.25M-$159.53M
Net Income-$244.09M-$122.31M-$147.03M-$116.95M$66.97M-$111.14M-$77.68M-$155.65M-$153.24M-$160.11M
EPS (Diluted)$-4.53$-2.27$-2.76$-2.47$1.38$-2.78$-1.95
Total Assets$326.80M$547.11M$696.38M$758.03M$609.37M$332.98M$419.27M$498.80M$496.33M$459.98M
Total Liabilities$46.33M$60.18M$135.02M$135.99M$143.32M$148.97M$146.35M$175.80M$89.14M$94.57M
Shareholders' Equity$280.47M$486.93M$561.37M$622.04M$466.04M$184.01M$272.92M$323.00M$407.19M$365.40M
Cash & Equivalents$307.53M$471.39M$618.83M$710.41M$579.09M$295.38M$375.72M$427.66M$417.62M$386.92M
Operating Cash Flow-$163.58M-$150.05M-$133.91M-$108.82M$92.61M-$80.36M-$52.97M-$28.28M-$131.18M-$116.25M
Shares Outstanding53.83M53.83M53.68M52.10M46.66M39.92M39.90M39.86M38.48M34.75M